Foresee Pharmaceuticals Co., Ltd.: Foresee Pharmaceuticals Announces European Commission Approval of CAMCEVI for the Treatment of Advanced Prostate Cancer; Accord Healthcare to Head the E.U. Commercialization
TAIPEI, May 31, 2022 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the European Commission (EC) has approved the Marketing Authorization Application (MAA)
Source: finanznachrichten.de